PÉREZ FIERRO , Manuel Luis

Antecedentes: Se evalúan la pérdida del implante y la pérdida ósea marginal a los 2 años en pacientes con coagulopatías hereditarias, en comparación con un grupo de control sano. Material y Métodos: se evalúan 37 implantes en 13 pacientes (17 con hemofilia A, 20 con enfermedad de von-Willebrand) en comparación con 26 implantes en 13 pacientes...

Objective: Analyze the 2-year clinical performance of single-unit titanium-zirconium (TiZr) alloy narrow-diameter (3.3 mm) dental implants with a hydrophilic surface (Straumann® Roxolid®, SLActive®) in patients with controlled type 2 diabetes mellitus (T2DM), measured using the glycated hemoglobin A (HbA1c) concentration test, compared with...

Background: The objectives were to evaluate the bone loss (BL) around narrow diameter implants (3.3 mm) 2 years after implant loading and compare with the bone loss around conventional-diameter implants (4.1 mm), as well as with clinical and anatomical variables. 2-years follow-up. Material and Methods: Cases: 20 patients either gender-age,...

Background: Evaluating 2-years implant loss and marginal bone loss in patients with hereditary coagulopathies, comparing with a healthy control group. Material and Methods: 37 implants in 13 patients (17 haemophilia A, 20 Von-Willebrand disease) versus 26 im plants in 13 healthy patients. Data measured through Lagervall-Jansson index (after...